证券记录 · 已归档季度
CSTL
Castle Biosciences, Inc. · Healthcare · Medical - Diagnostics & Research
11被追踪持有人
+2Δ持有人
4.84M持有股份
$128.97M报告持仓市值
+4新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 +22.2% ·
股份流向 +30.0% ·
净新建仓位 +18.2%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 76 | -1 | 16.76M | $400.39M | +6 | −6 |
| Q1 2026 | 79 | -9 | 16.13M | $395.93M | +4 | −13 |
| Q4 2025 | 87 | +2 | 17.12M | $665.58M | +2 | — |
| Q3 2025 | 16 | 0 | 9.41M | $214.29M | +1 | −1 |
| Q2 2025 | 13 | -1 | 9.39M | $191.81M | — | −1 |
| Q1 2025 | 11 | 0 | 4.13M | $82.76M | +1 | −1 |
| Q4 2024 | 11 | +2 | 4.84M | $128.97M | +4 | −2 |
| Q3 2024 | 8 | 0 | 2.64M | $75.25M | — | — |
| Q2 2024 | 8 | — | 1.95M | $42.47M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 834.51K | +31.8% | $22.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 834.51K | +31.8% | $22.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 722.12K | 新增 | $19.24M | 0.0% | New | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 722.12K | 新增 | $19.24M | 0.0% | New | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 722.12K | 新增 | $19.24M | 0.0% | New | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 722.12K | 新增 | $19.24M | 0.0% | New | 1 | SEC ↗ |
| 7 | State Street Global Advisors ✦ (被动) | 710.21K | — | $18.93M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 685.00K | +39.9% | $18.26M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Geode Capital Management ✦ (被动) | 628.20K | +0.6% | $16.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Geode Capital Management ✦ (被动) | 628.20K | +0.6% | $16.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Millennium Management ✦ | 548.81K | +290.5% | $14.63M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 547.10K | +9.6% | $14.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 90.56K | 新增 | $2.41M | 0.0% | New | 1 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 28.90K | 新增 | $770,265 | 0.0% | New | 1 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 22.70K | +8.8% | $605,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 21.11K | 新增 | $562,715 | 0.0% | New | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 21.11K | 新增 | $562,715 | 0.0% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 21.11K | 新增 | $562,715 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Wellington Management | $19.24M | 0.0% |
| Wellington Management | $19.24M | 0.0% |
| Wellington Management | $19.24M | 0.0% |
| Wellington Management | $19.24M | 0.0% |
| D. E. Shaw & Co. | $2.41M | 0.0% |
| Arrowstreet Capital | $770,265 | 0.0% |
| AQR Capital Management | $562,715 | 0.0% |
| AQR Capital Management | $562,715 | 0.0% |
| AQR Capital Management | $562,715 | 0.0% |
已清仓
| Marshall Wace | $6.30M | 曾为 0.0% |
| Two Sigma Investments | $279,496 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 186 持有人, 27.52M 股份, $653.08M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 17
Juvenal Tobin W
Officer · 1.73K 股 · $51,191
Aug 14
MAETZOLD DEREK J
Officer, Director · 1.10K 股 · $33,022
Aug 14
MAETZOLD DEREK J
Officer, Director · 2.71K 股 · $81,474
Aug 14
MAETZOLD DEREK J
Officer, Director · 2.31K 股 · $69,226
Aug 14
MAETZOLD DEREK J
Officer, Director · 278 股 · $8,346
Aug 14
Stokes Frank
Officer · 24.91K 股 · $741,511
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据